Immediate Impact

62 standout
Sub-graph 1 of 22

Citing Papers

Cell death
2024 Standout
Crohn's disease
2024 Standout
1 intermediate paper

Works of B G Feagan being referenced

OP17 Upadacitinib Improves Endoscopic Outcomes in Patients with Moderate to Severely Active Crohn’s Disease Irrespective of Previous Failure to Respond to Biologics or Conventional Therapies
2023
P434 Upadacitinib improved fatigue and health-related quality of life in patients with moderately to severely active Crohn’s disease: Results from induction and maintenance phase 3 trials
2023
and 1 more

Author Peers

Author Last Decade Papers Cites
B G Feagan 358 252 194 26 491
David Drobne 406 278 211 50 565
Mélanie Rinaudo-Gaujous 321 225 174 15 474
I. O. Auer 305 241 203 28 521
Mark G. Ward 356 246 192 43 530
Miroslava Volfová 359 271 194 15 499
Gregor Novak 363 281 133 27 475
Idan Levy 257 201 118 20 564
Simon Hirschmann 337 181 267 25 536
A Dasgupta 191 166 135 16 474
Phillip Minar 310 204 213 39 422

All Works

Loading papers...

Rankless by CCL
2026